Optimizing Bone Graft Outcomes with PRF and PRP
Enhancing Healing in Oral Surgery

PRF and PRP are autologous biologics derived from a patient's blood, enhancing bone graft healing. They concentrate platelets and growth factors to stimulate tissue regeneration.

While both serve a similar purpose, their preparation and properties differ. PRP, a first-generation concentrate, requires anticoagulants and a two-step centrifugation, yielding liquid plasma. PRF is a second-generation product prepared via a simpler, single-step centrifugation at ~2700 RPM for 12 minutes without additives. This creates a dense, cross-linked fibrin matrix providing sustained growth factor release over 7-10 days.

• Preparation: PRP requires a two-step spin with anticoagulant; PRF uses a single, faster spin without additives.
• Structure: PRP is liquid plasma; PRF forms a solid, manageable fibrin clot for plugs or membranes.
• Growth Factor Release: PRF offers slow, sustained release, mimicking natural healing; PRP delivers a rapid, short-lived burst.
• Cellular Content: The PRF matrix entraps more leukocytes and circulating stem cells, enhancing regenerative and antimicrobial properties.

PRF and PRP boost bone regeneration by delivering a supra-physiological dose of autologous growth factors that orchestrate the healing cascade. This bio-stimulation accelerates soft tissue closure and underlying hard tissue maturation.

Primary mechanism involves concentrated platelet degranulation, releasing critical signaling proteins like Platelet-Derived Growth Factor (PDGF), Transforming Growth Factor-beta (TGF-β), and Vascular Endothelial Growth Factor (VEGF). These powerful chemoattractants recruit mesenchymal stem cells, inducing their differentiation into osteoblasts. This osteoinduction, combined with enhanced angiogenesis, results in faster, denser bone formation within the graft.

• Angiogenesis: VEGF stimulates rapid new blood vessel formation, ensuring the graft receives oxygen and nutrients.
• Osteoinduction: PDGF and TGF-β directly signal osteoprogenitor cells to proliferate and differentiate into bone-forming osteoblasts.
• Scaffolding: The PRF fibrin matrix provides a stable 3D scaffold, facilitating cell migration and tissue organization.
• Inflammatory Modulation: Leukocytes within the PRF clot help regulate local inflammation, reducing post-operative edema and discomfort.

PRF and PRP are widely used in oral surgery to improve outcomes in procedures requiring predictable hard and soft tissue healing, from routine extractions to complex implant and periodontal surgeries.

PRF's versatility is key; the fibrin clot can be used whole as a 'plug' for socket preservation or compressed into a durable membrane for guided bone regeneration (GBR). Mixed with particulate bone graft, it forms cohesive 'sticky bone,' excellent for sinus augmentation and filling large defects, improving graft stability and handling.

• Socket Preservation: Placing a PRF plug in an extraction socket protects the blood clot and reduces alveolar ridge resorption by up to 50%.
• Sinus Augmentation: 'Sticky bone' with PRF simplifies graft placement and containment during lateral or crestal sinus lift procedures.
• Periodontal Defects: PRF membranes treat intrabony and furcation defects, promoting cementum, PDL, and alveolar bone regeneration.
• Implant Dentistry: Applied around implants to enhance primary stability and accelerate osseointegration, especially in compromised bone.

Chairside PRF/PRP preparation requires minimal, specific sterile equipment, centered on a medical-grade centrifuge. The protocol is efficient, taking only 15-20 minutes from blood draw to application.

The most critical piece is a dedicated PRF centrifuge, calibrated for specific RCF/g-force for optimal platelet separation without hemolysis. A standard lab centrifuge is often inadequate. The process also requires a sterile phlebotomy kit and a specialized PRF fabrication kit to process the clot into membranes or plugs.

• Centrifuge: Must have a fixed-angle rotor and precise settings for required g-force (e.g., ~700 g for L-PRF).
• Blood Collection Tubes: Use sterile, vacuum-sealed glass or silica-coated tubes without anticoagulants for PRF; with sodium citrate for PRP.
• Phlebotomy Supplies: Includes tourniquet, 21-gauge butterfly needles, and alcohol swabs for aseptic blood draw.
• Fabrication Kit: A sterile PRF box with a tray, press, and instruments shapes the clot into consistent membranes/plugs.

PRF/PRP with bone grafts offers significant patient benefits: faster, more comfortable, and predictable recovery. As 100% autologous, it eliminates risks of allogeneic/xenogeneic products.

High leukocyte concentration within the PRF matrix modulates inflammation, reducing post-operative pain and swelling. Accelerated soft tissue closure creates a biological barrier, lowering infection incidence and complications like dry socket. These advantages improve patient experience and overall graft success.

• Faster Healing: Patients experience quicker soft tissue closure and bone regeneration, shortening treatment timelines.
• Reduced Discomfort: Anti-inflammatory effects of concentrated leukocytes significantly decrease post-surgical pain and edema.
• Lower Complication Risk: Autologous nature eliminates disease transmission risk; fibrin barrier protects against infection.
• Enhanced Predictability: Improves bone graft success, especially in systemically compromised patients or challenging clinical scenarios.